Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation
about
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesAlternative Donor Transplantation for Acute Myeloid LeukemiaPreventing stem cell transplantation-associated viral infections using T-cell therapyT lymphocytes targeting native receptorsPosttransplant lymphoproliferative disease after pediatric solid organ transplantationAntiviral T-cell therapyLong-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersHaploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjectsDifferential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients.Short-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical applicationCytotoxic T lymphocytes as immune-therapy in haematological practice.Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersAn overview of viral oncology in Italy - report from the Pavia meeting on solid tumors.Haploidentical transplantation for hematologic malignancies: where do we stand?Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation.Adoptive cellular immunotherapy for viral diseases.Searching for alternative hematopoietic stem cell donors for pediatric patients.T cell therapy in allogeneic stem cell transplantation.Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in ChildhoodT cells for viral infections after allogeneic hematopoietic stem cell transplantImmunotherapy targeting EBV-expressing lymphoproliferative diseasesHow I treat EBV lymphoproliferation.Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care.Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.Immunotherapy against EBV-lymphoma in recipients of HSCT.Immunotherapy for EBV-associated malignancies.Immunotherapy for epstein-barr virus-related lymphomas.Is adoptive T-cell therapy for solid tumors coming of age?T-cell therapies for Epstein-Barr virus-associated lymphomas.Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?T-cell therapy in the treatment of post-transplant lymphoproliferative diseaseDetermining EBV load: current best practice and future requirements.EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.
P2860
Q26745838-9295B91B-3480-4754-9B73-51AD56B27C5BQ26799456-0BDDDBCE-A494-4733-9269-D4524F578534Q26801365-19E198DB-C505-4C6D-8F16-4478703FA5BDQ26853345-5C7F4451-AC0B-4763-83E1-89A2D90B527CQ26866013-C4300BA6-B501-4426-8EB8-DD0781CE2248Q27028006-1E46BBB6-9E44-446D-8077-94BFFCC10FBEQ33634455-21049AF1-DB86-49DD-B5B2-7105272993C8Q33713932-66354B5A-6E7A-4C8A-9D3C-B5C93F34A887Q34166602-F79DBF3E-4C73-4285-96A3-99E19F6738F6Q34232835-43C90898-4327-4B5F-990D-17D18925A88EQ34374139-1702DC93-88EF-42E6-8F2D-03E4BEAC07D7Q34432181-D404DC76-01B0-45B0-945E-67BC3A0E13FFQ34695369-B25FDFAA-C325-4424-AF7E-3D8AC0767C8FQ35157540-D7C8958E-3247-46D4-B084-B1DC5893DCF4Q35738744-0CCABAA5-E69B-4221-9484-4D8A98116467Q36468756-41710DEF-4D88-4F83-BBA2-BCAAF417E4B6Q36854831-4D09FFB2-5E42-4E52-99A2-8CB680235416Q36957919-EFF8A3B1-8977-4199-B3B7-4BF500C3CAA0Q36992981-446BE099-5059-41F2-9DD6-18481004D82EQ37033846-52E11A6B-DE99-4AA0-97A7-43E0ABE5F0BAQ37045973-689190DD-FB25-4C38-A9A7-7B32B6491D3EQ37051052-25E42461-B692-4DBE-9F8D-995F9D5EB36BQ37055896-F43F1C6E-255A-4C9F-926C-87964B798CBDQ37058107-0E3823E8-C36B-4552-A89C-DCA8927DE93EQ37268305-CE3E9130-7BE4-458C-A280-E316AAF03F44Q37414678-FD32154A-5D10-4233-8B64-1867F3FB959DQ37426542-942D23D0-E5E8-4721-8A2C-967DFDAB0046Q37592177-7CC05A94-5316-4B0A-9900-474BA3B3E812Q37687412-362E6893-3002-482F-B5CB-29775B06D9B9Q37726624-4CFDF91E-DABE-489F-8A94-715EFDF37067Q37810283-22665DCD-33F7-4F9C-B827-9331BD61AA0AQ37845178-9F22D8A6-4EA0-4216-8F3A-BB7CA5D40620Q37854471-5B06955E-7B2D-4A5F-B4A9-5A35EBFE6D6EQ37909004-CE57EBD7-F835-4D48-9173-E3C3A81C6BF5Q37948940-A1C977EC-00D0-48BB-A8C7-95B18ABE98B3Q38002109-91F1030C-A278-47E3-A1D7-0DE205513117Q38026406-A9FFE267-6A66-407E-8383-C7B89A22413CQ38026758-1690C47A-2191-455D-BDA4-5DF6174B7598Q38079834-175098AC-E1A6-424C-8F25-FA0F90B39DA9Q38119843-28DB4073-F4AF-47F1-9907-5F49880A0DE0
P2860
Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation
description
im Juni 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 June 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2007
@uk
name
Preemptive Therapy of EBV-Rela ...... ical Stem Cell Transplantation
@en
Preemptive Therapy of EBV-Rela ...... ical Stem Cell Transplantation
@nl
type
label
Preemptive Therapy of EBV-Rela ...... ical Stem Cell Transplantation
@en
Preemptive Therapy of EBV-Rela ...... ical Stem Cell Transplantation
@nl
prefLabel
Preemptive Therapy of EBV-Rela ...... ical Stem Cell Transplantation
@en
Preemptive Therapy of EBV-Rela ...... ical Stem Cell Transplantation
@nl
P2093
P2860
P50
P1476
Preemptive therapy of EBV-rela ...... ical stem cell transplantation
@en
P2093
Bernardo ME
Locatelli F
Maccario R
Pagliara D
P2860
P304
P356
10.1111/J.1600-6143.2007.01823.X
P407
P577
2007-06-01T00:00:00Z